1 results match your criteria: "Endocrine and Polypeptide Institute[Affiliation]"
Rev Endocr Metab Disord
November 2024
Miami VA Healthcare System, Endocrine and Polypeptide Institute, Miami, FL, USA.
Growth Hormone-Releasing Hormone (GHRH) and its analogs have gained significant attention for their therapeutic potential across various domains, including oncology, regenerative medicine, and metabolic disorders. Originally recognized for its role in regulating growth hormone (GH) secretion, GHRH has since been discovered to exert broader physiological effects beyond the pituitary gland, with GHRH receptors identified in multiple extrahypothalamic tissues, including tumor cells. This review explores the development of both GHRH agonists and antagonists, focusing on their mechanisms of action, therapeutic applications, and future potential.
View Article and Find Full Text PDF